Your browser doesn't support javascript.
loading
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Loke, Justin; Labopin, Myriam; Craddock, Charles; Cornelissen, Jan J; Labussière-Wallet, Hélène; Wagner-Drouet, Eva Maria; Van Gorkom, Gwendolyn; Schaap, Nicolaas P M; Kröger, Nicolaus M; Veelken, Joan Hendrik; Rovira, Montserrat; Menard, Anne Lise; Bug, Gesine; Bazarbachi, Ali; Giebel, Sebastian; Brissot, Eolia; Nagler, Arnon; Esteve, Jordi; Mohty, Mohamad.
Affiliation
  • Loke J; Cancer Research UK, Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Labopin M; Birmingham Center for Cellular Therapy and Transplantation, Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.
  • Craddock C; Acute Leukemia Working Party, Paris Study Office, European Society for Blood and Marrow Transplantation, Paris, France.
  • Cornelissen JJ; Haematology Department, AP-HP, Saint Antoine Hospital, Paris, France.
  • Labussière-Wallet H; INSERM, Centre de Recherche Saint-Antoine (CRSA), Sorbonne Universités, UPMC Univ Paris 06, Paris, France.
  • Wagner-Drouet EM; Cancer Research UK, Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Van Gorkom G; Birmingham Center for Cellular Therapy and Transplantation, Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.
  • Schaap NPM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Kröger NM; Hopital-Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Veelken JH; Department of Hematology, Oncology, and Pneumology, University Medical Center Mainz, Mainz, Germany.
  • Rovira M; Department Internal Medicine Hematology/Oncology, University Hospital Maastricht, Maastricht, The Netherlands.
  • Menard AL; Radboud University Medical Centre Nijmegen, The Netherlands.
  • Bug G; University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany.
  • Bazarbachi A; Leiden University Hospital, BMT Centre Leiden, Leiden, The Netherlands.
  • Giebel S; Hospital Clinic, Department of Hematology, IDIBAPS, Barcelona, Spain.
  • Brissot E; Centre Henri Becquerel, Hematology, Rouen, France.
  • Nagler A; Department of Medicine, Goethe University Frankfurt, Frankfurt Main, Germany.
  • Esteve J; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Mohty M; Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut, Lebanon.
Cancer ; 128(15): 2922-2931, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35612815
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Year: 2022 Document type: Article Affiliation country: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Year: 2022 Document type: Article Affiliation country: Reino Unido